Abbott (ABT) Technical Analysis — Chart, Levels & News

Signal — short-term technical (daily chart)

On the short-term daily chart horizon, Abbott Laboratories exhibits a bullish technical bias driven by positive momentum across key oscillators and price positioning. Conviction is moderately positive, supported by supportive moving average relationships and confirmed buying triggers on the latest completed bar. No candlestick pattern was detected on the latest completed bar.

News, Macro & Industry Context

The medium-term narrative tone is positive, underpinned by robust fundamentals and strategic expansions. Abbott Laboratories recently reported third-quarter sales of USD 13.01 billion, driven by strength in diagnostics expansion and device demand, which helped offset reported legal settlement costs. Further expanding its portfolio, Abbott launched the whole-genome sequencing Oncodetect molecular residual disease test to detect cancer traces in blood for over 3 million U.S. patients with solid tumors, alongside announcing commercial availability. In addition, the company scheduled a USD 0.63 dividend payable on November 16, 2026, reinforcing its standing as a dividend king. Analysts have responded favorably, with Baird raising its stock target from USD 121.00 to USD 123.00, while broader commentary highlights a continuing growth story bolstered by device innovation and strategic portfolio refinement. This company-specific momentum unfolds against a broader macroeconomic backdrop characterized by a choppy, sideways market environment, elevated credit spreads, and safe-haven flows supporting the U.S. dollar, while investors navigate looming central bank policy decisions and sticky inflation pressures.

Catalysts

Upcoming catalysts include upcoming corporate earnings reports across the broader healthcare and technology sectors, scheduled macroeconomic data prints such as PCE, and the upcoming Federal Open Market Committee meeting where interest rate stability is largely anticipated.

Levels & Risk

Key price levels feature volume profile resistance at the Value Area High (VAH) of 113.42, with the Volume Point of Control (VP POC) situated at 107.70. Fair Value Gap (FVG) resistance zones are identified at 105.19-105.24 and 106.86-107.36. Support is anchored by the Value Area Low (VAL) of 94.55 and multiple lower FVG zones spanning 97.59 to 100.63. Risk framing centers on potential macroeconomic volatility and broader market rotation, with a break below immediate moving average support acting as an invalidation level for the current short-term bullish technical setup.

Technical Breakdown

WaveTrend displays bullish momentum with fast lines above slow lines in the mid-range. SMI is bullish, remaining above its signal line in the mid-range. The trend shows price above the EMA20 indicating an uptrend bias, alongside the EMA5 positioned above the EMA13 reflecting short-term bullishness. Triggers show an active SMI and WaveTrend buy signal. No candlestick pattern was detected on the latest completed bar. Higher timeframe context shows no higher-timeframe extreme.